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Abstract Aims/hypothesis: Intake of n-3 polyunsaturated
fatty acids reduces adipose tissue mass, preferentially in the
abdomen. The more pronounced effect of marine-derived
eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids
on adiposity, compared with their precursor α-linolenic
acid, may be mediated by changes in gene expression and
metabolism in white fat. Methods: The effects of EPA/
DHA concentrate (6% EPA, 51% DHA) admixed to form
two types of high-fat diet were studied in C57BL/6J mice.
Oligonucleotide microarrays, cDNA PCR subtraction and
quantitative real-time RT-PCR were used to characterise
gene expression. Mitochondrial proteins were quantified
using immunoblots. Fatty acid oxidation and synthesis were
measured in adipose tissue fragments. Results: Expression
screens revealed upregulation of genes for mitochondrial
proteins, predominantly in epididymal fat when EPA/DHA
concentrate was admixed to a semisynthetic high-fat diet
rich in α-linolenic acid. This was associated with a three-
fold stimulation of the expression of genes encoding reg-
ulatory factors for mitochondrial biogenesis and oxidative
metabolism (peroxisome proliferator-activated receptor gamma
coactivator 1 alpha [Ppargc1a, also known as Pgc1α] and
nuclear respiratory factor-1 [Nrf1] respectively). Expression of
genes for carnitine palmitoyltransferase 1A and fatty acid
oxidationwas increased in epididymal but not subcutaneous
fat. In the former depot, lipogenesis was depressed. Similar
changes in adipose gene expression were detected after re-
placement of as little as 15% of lipids in the composite high-
fat diet with EPA/DHA concentrate, while the development
of obesity was reduced. The expression of Ppargc1a and
Nrf1 was also stimulated by n-3 polyunsaturated fatty acids
in 3T3-L1 cells. Conclusions/interpretation: The anti-
adipogenic effect of EPA/DHA may involve a metabolic
switch in adipocytes that includes enhancement of β-ox-
idation and upregulation of mitochondrial biogenesis.
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Introduction
Type 2 diabetes exhibits a much stronger dependence on
obesity than other health consequences of excessive ac-
cumulation of body fat. One of the major causes of obesity
is high intake of lipids [1]. Studies in rodents [2–7] have
demonstrated that saturated fats facilitate adipose tissue
deposition more effectively than polyunsaturated fatty
acids (PUFA). The long-chain n-3 PUFA eicosapentaenoic
acid (EPA; 20:5 n-3) and docosahexaenoic acid (DHA,
22:6 n-3), which are abundant in marine fish oil, are more
potent in reducing adiposity than n-3 PUFA from plants,
such as α-linolenic acid (ALA, 18:3 n-3 [4, 8]). The intake
of DHA appears to be particularly important [5, 8]. In
mammals, ALA is a precursor of EPA and DHA, but is
rapidly oxidised in the organism and its conversion to EPA
and DHA is quite inefficient [6, 9, 10]. Hence, dietary fish
oil supplement is a more effective source of tissue DHA
than ALA [6, 10]. Also in humans, dietary fish oil may
decrease body fat content [11]. Furthermore, EPA and
DHA act as hypolipidaemics, exert prophylactic effects on
cardiovascular disease and may improve insulin sensitivity
(references, see [4, 9]). Therefore, current dietary recom-
mendations favour a substantial decrease in the n-6: n-3
PUFA ratio [6, 9].
The effect of n-3 PUFA on fat deposition does not result
from a reduction in food intake [2–6, 8, 11], but rather
reflects metabolic changes in several tissues [6, 12], such as
stimulation of lipid oxidation and inhibition of lipogenesis
in liver (references, see [6, 12]), stimulation of fatty acid
oxidation in muscle [13], as well as adaptive thermogenesis
mediated by mitochondrial uncoupling protein 1 (UCP1) in
brown fat [2, 14]. In humans, whole-body lipid oxidation
was increased by dietary fish oil [11]. The anti-adipogenic
effect of n-3 PUFA may be also mediated by changes
occurring in white adipose tissue itself [5, 15]. Studies in
rodents indicate a complex modulation of gene expression
in white adipose tissue by n-3 PUFA [6, 12], especially in
fat depots in the abdominal region, which are preferentially
reduced [3, 5, 6, 8, 16]. The changes in gene expression
suggest a decrease in lipogenesis and fatty acid release
from adipocytes [5] and an enhancement of mitochondrial
respiration [3] and glucose uptake [8] in these cells.
The main goals of this study were to investigate the
effects of EPA and DHA, compared with ALA, on gene
expression in white adipose tissue, and to test the hy-
pothesis that these effects limit the development of obesity.
Experiments were conducted in mice fed two types of high-
fat diet, either a semisynthetic diet (sHFf) or a composite
diet based on chow (cHF; see Materials and methods and
[8]). The sHFf diet is well defined and made it possible to
study the separate effects of EPA and DHA, and ALA,
respectively. Similar purified diets have been used in
previous studies in rodents. While these diets do not
promote obesity in mice [2–5, 8, 13, 14], the cHF diet does
[8, 17]. We show here that replacement of some of the
dietary lipids with EPA and DHA induced expression of
mitochondrial genes in white adipose tissue, as well as the
gene encoding their upstream regulatory factor, PPARγ
coactivator-1α (PPARGC1A, also known as PGC1α). This
factor links nuclear receptors to the transcriptional program
of mitochondrial biogenesis and oxidative metabolism in
adipocytes and muscle cells [18–20] and to gluconeogen-
esis in liver [21]. We also demonstrate that the expression
of the gene for carnitine palmitoyltransferase 1A(Cpt1a)
and oxidation of fatty acids was stimulated in epididymal
but not subcutaneous white adipose tissue. Our data sug-
gest that upregulation of mitochondrial biogenesis and
induction of β-oxidation, as well as suppression of lipogen-
esis in adipocytes, are involved in the preferential reduction of
lipid accumulation by EPA and DHA in abdominal fat.
Materials and methods
Animals and diet
Male C57BL/6J mice were imported from the Jackson
Laboratory (Bar Habor, ME, USA) and bred at the Institute
of Physiology for up to 16 generations. Male mice were
used for the experiments. Animals were housed in a
controlled environment (20°C; 12-h light–12-h dark cycle;
light from 06.00 h) with free access to water and standard
chow [17]. At 4 months of age, singly caged animals were
randomly assigned for 4 weeks to one of the high-fat diets
described previously (see Tables 1, 2, 3 of Ref. [8] and the
Electronic Supplementary Material [ESM] Tables 1 and 2);
the sHFf diet, which contained 20% (wt/wt) flax-seed oil
(rich in ALA) as the only lipid; or the sHFf-F2 diet, which
had the same composition as the preceding diet except that
44% of lipids were replaced by n-3 PUFA concentrate
containing 6% EPA and 51% DHA (EPAX 1050TG;
Pronova Biocare, Lysaker, Norway; EPA/DHA concen-
trate). Some 4-month-old animals were also habituated for
2 weeks to the cHF diet, derived from standard chow and
containing 35% (wt/wt) lipids of very low n-3 PUFA
content. These were then assigned for 5 weeks to the cHF
diet or to the cHF-F1 diet, which had the same composition
as the cHF diet except that 15% (wt/wt) of lipids were
replaced with EPAX 1050TG [8]. Individual food intake
was determined as before [8]. Mice were killed by cervical
dislocation and subcutaneous dorsolumbar and epididymal
white adipose tissue depots [8] were dissected. Tissues
were either used immediately for measurement of fatty acid
metabolism, or stored in liquid nitrogen for RNA analysis
and immunoblotting. The experiments were conducted
under the guidelines for the use and care of laboratory
animals of the Institute of Physiology, Academy of Sciences
of the Czech Republic.
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Differentiation of 3T3-L1 adipocytes
Eleven days after induction of cell differentiation [22] and
24 h before RNA isolation, a complete change of the
medium was performed using serum-free Dulbecco’s mod-
ified Eagle medium containing 0.5% fatty acid-free BSA,
830 nmol/l insulin and 0.5 mmol/l oleic acid in the form of
BSA/fatty acid sodium salt. Medium was further supple-
mented with ethanolic solution of fatty acid: (1) 0.2 mmol/l
oleic acid; (2) 0.2 mmol/l ALA; or (3) 0.2 mmol/l DHA, and
incubated for 1 h before use.
RNA isolation
Total RNA was isolated and purified using the TRIzol
Reagent (Invitrogen, Carlsbad, CA, USA) according to the
protocol of the supplier with additional phenol/chloroform
extraction.
DNA and protein content
DNA was measured fluorometrically in tissue samples
digested with proteinase K, and protein concentration was
assessed using the bicinchoninic acid procedure and BSA
as standard [23].
cDNA PCR subtraction
RNA was isolated from epididymal fat pads pooled from
six mice fed the sHFf or the sHFf-F2 diet. cDNA was
generated using the SMART PCR cDNA Synthesis Kit (BD
Biosciences, San Jose, CA, USA). To detect the genes up-
regulated by the sHFf-F2 diet, PCR-based cDNA subtrac-
tion was carried out with the PCR-Select cDNA Subtraction
Kit (BD Biosciences). Subtracted cDNA libraries were
subcloned (T/A cloning) into bacteria and analysed by
colony array hybridisation using 32P-labelled cDNA probes
(DECAprime II DNA Labeling Kit; Ambion, Austin, TX,
USA). Selected cDNAs were sequenced (DNA sequencer
CEQ2000XL; Beckman Coulter, Harbor Boulevard, CA,
USA) and DNA sequences were analysed using BLAST
(GenBank, NIH).
Oligonucleotide microarray
Each RNA sample isolated from dorsolumbar and epidid-
ymal fat of sHFf and sHFf-F2mice (nine animals per group)
was indirectly labelled [24] and processed separately. In the
reverse transcription step, aminoallyl dUTP was incorpo-
rated and then chemically coupled to fluorophores. RNA
samples (30 μg) were separately labelled with Cy5 dye. A
common reference sample (a pool representing all the
investigated samples) was also labelled with Cy3. High-
density microarrays, based on commercial oligonucleotide
library (Mouse 10k A set; MWG Biotech, Ebersberg bei
München, Germany) were printed on epoxy slides (Quanti-
foil, Jena, Germany) using a MicroGrid II (Genomic
Solutions, Ann Arbor, MI, USA), pretreated, hybridised
overnight at 42°C in a humid hybridisation chamber, and
read using a laser scanner (ScanArray Express; Perkin-
Elmer, Boston, MA, USA). To correct for fluctuations in
RNA sample size and the amount of DNA spotted, signals
were normalised [25]. All Cy3 and Cy5 signals lower than
2.5-fold background value were excluded from the analysis
(approximately 60% of spots). Identification of differen-
tially expressed geneswas done using discriminant analysis,
which is a supervised form of principal components analysis
(Genemath software; Applied Maths, Sint-Martens-Lathem,
Belgium). Sampleswere first assigned to their diet intervention
group, then separated along the dimension of maximum
Table 1 Effects of EPA/DHA concentrate on body weight, fat depots and food consumption
Diet
sHFf sHFf-F2 cHF cHF-F1
Body weight (g)
Initiala 26.4±0.5 26.4±0.4 27.5±0.6 27.8±0.7
Finala 26.9±0.7 23.4±0.6b 35.4±1.1 33.4±0.7
Changea 0.4±0.5 −2.9±0.8b 7.75±0.7 6.25±0.6c
Epididymal fat weight (mg) 481±38 326±24b 2093±97 1741±122c
Dorsolumbar fat weight (mg) 215±12 197±16 679±45 640±40
Food consumptiona (kJ/day per animal) 71.2±6.2 70.8±5.1 65.5±3.1 66.3±4.2
n 12 12 11 12
Data are means±SEM
Mice were fed semisynthetic diets (sHFf or sHFf-F2) and used for the analysis of gene expression in adipose tissue (Table 2, Fig. 2), or fed
composite diets (cHF or cHF-F2) and used for the analysis of gene expression in collagenase-liberated adipocytes (Table 4)
aWith respect to the whole period of dietary treatment
bStatistically significant difference compared with sHFf diet
cStatistically significant difference compared with cHF diet
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variation in gene expression between the groups and the
0.5% of genes that contributed most to the variation (the
discriminating genes) were subsequently selected. Finally,
from the selected genes only those genes were considered
that exerted significantly different (t-test) levels of expres-
sion in at least one of the tissues analysed.
Quantitative real-time RT-PCR
This analysis (qRT-PCR) was performed using a PCR kit
(QuantiTect SYBR Green; Qiagen, Hilden, Germany) and
LightCycler (Hoffman-La Roche, Basel, Switzerland). All
samples were treated with DNAase. Dilution of cDNA
samples before PCR quantification of mitochondrially en-
coded genes was 100-fold higher compared with nuclear-
encoded genes. Levels of all transcripts were correlatedwith
that of the gene for cyclophilin-β since quantity of this
transcript is not affected by the dietary treatments [8] and is
expressed in arbitrary units (AU). Lasergene software
(DNAStar, Madison, WI, USA) was used to design oligo-
nucleotide primers (see ESM Table 3).
Quantification of mitochondrial proteins
Frozen tissues were immersed in a buffer containing 0.25 mol/l
sucrose, 50 mmol/l Tris and 5 mmol/l EDTA (pH 7.5), and
homogenised for 7 min on ice using a Teflon/glass homo-
geniser. Tissue fragments were removed by centrifugation
for 10 min at 4°C and 600 g and crude cell membranes
were separated from the supernatant by centrifugation for
35 min at 4°C and 100,000 g. Samples of the crude cell
membranes were analysed using SDS-PAGE and immu-
noblots [26]. Polyclonal rabbit antibody [26] was used
(1:5,000) to detect cytochrome c oxidase subunits I and VI
(MT-CO1 and COX6). Monoclonal antibody was used to
detect the 70 kDa subunit of complex II (SDHA; 1:2,000;
Molecular Probes A-11142, Eugene, OR, USA) and
subunit α of F1-ATPase (ATP5A1; 1:200,000, lot 20D6
[27]). Peroxidase-labelled goat anti-mouse IgG (1:1,000,
A8924; Sigma, St Louis, MO, USA) or goat anti-rabbit IgG
(1:1,000, F0382; Sigma) was used as a secondary antibody.
Antigens were visualised by luminescence and detected on
a LAS 1000 CCD camera system (Fuji, Tokyo, Japan).
Liver mitochondria isolated from chow diet-fed mice were
used as standard to quantify the relative content of each
antigen.
Oxidation and synthesis of fatty acid in fragments
of adipose tissue
Fatty acid oxidation was measured as the amount of radio-
activity released into the medium from fragments (50 mg
tissue chopped into about ten pieces using a razor blade)
prelabelled with [9,10(n)-3H]oleic acid [28]. Synthesis of
fatty acids was measured as before [22] except that the
medium also contained 1mMpyruvate and 3H2O (18.5MBq/
ml) was used instead of radioactive glucose.
Statistics
The data were evaluated by one-way (diet) or two-way
ANOVAwith one grouping factor (diet) and one trial factor
(depot). Logarithmic or square root transformation was
used to stabilise variance in cells when necessary. The
Spearman correlation coefficient was used to evaluate the
relationship between transcript levels. The level of sig-
nificance for all tests was set at p=0.05.
Results
Screening for genes regulated by EPA and DHA
in white adipose tissue
To identify the genes specifically regulated in white adipose
tissue by marine-derived n-3 PUFA, mice were maintained
for 4weeks on the sHFf diet, rich inALAand free ofDHAor
EPA,while the othermicewere fed a similar diet, except that
44% of dietary lipids were replaced by EPA/DHA concen-
trate (sHFf-F2 diet). In accordance with previous results [8],
animals fed the sHFf diet maintained stable body weight
during 4 weeks of the treatment, while in the sHFf-F2 group
the mean body weight declined by 11±2%. The weight of
epididymal fat was 30±3% lower than in the sHFf group
(mean±SEM of four independent experiments, n=7–12),
while the weight of dorsolumbar fat did not change sig-
nificantly. As observed before [8], food consumption was
not affected (Table 1).
Table 3 Quantification of the protein components of the oxidative phosphorylation system in sHFf and sHFf-F2 diet-fed mice
Fat depot Diet SDHA MT-CO1 COX6 ATP5A1
Epididymal fat sHFf 0.25±0.04 0.37±0.07 0.28±0.02 0.30±0.06
sHFf-F2 0.48±0.06a 0.68±0.08a 0.67±0.14a 0.44±0.03a
Dorsolumbar fat sHFf 0.42±0.04b 0.34±0.06 0.43±0.08 0.33±0.07
sHFf-F2 0.46±0.07 0.32±0.07b 0.38±0.07 0.39±0.07
Individual antigens were quantified in crude cell membranes isolated from adipose tissues using immunoblots and their content was
expressed in AU using isolated mouse liver mitochondria as a standard (see Fig. 1)
Data are means±SEM (n=9). The effect of diet in fat depots (two-way ANOVA) was different, except for ATP5A1
aSignificant differences between diets
bSignificant differences between fat depots
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First, cDNA PCR subtraction was used to identify genes
upregulated in the sHFf-F2-fed mice, starting from total
RNA prepared from epididymal pads pooled from mice fed
either the sHFf or the sHFf-F2 diet. In total, 52 clones were
identified corresponding to 19 differentially expressed
genes, six of them having known functions (Table 2):
genes for cytochrome c oxidase subunit III (mt-Co3) and
subunit 6 of ATPase (mt-Atp6), i.e. the key components of
the mitochondrial oxidative phosphorylation system, en-
coded by mitochondrial DNA, and four nuclear genes
engaged in regulatory pathways.
Secondly, oligonucleotide microarray analysis was ap-
plied to RNA samples isolated from both epididymal and
dorsolumbar fat. Tissues from individual animals fed either
sHFf or sHFf-F2 diet (Table 1) were processed and analysed
separately. Only 0.5% of the genes most discriminating in
both directions (see Materials and methods) between the
sHFf and sHFf-F2 diets were considered (Table 2). In ac-
cordance with the results of cDNA PCR subtraction, the
majority of the most upregulated genes in both fat depots of
the sHFf-F2-fed mice belong to the mitochondrial genome
and code for components of the oxidative phosphorylation
system (complex I, cytochrome c oxidase and complex V,
ATP synthase). Also, the nuclear gene for adipsin, the
adipocyte hormone engaged in the control of fatty acid
intake [29], was upregulated. Conversely, the most down-
regulated genes in the sHFf-F2-fed animals were those
supporting lipogenesis and encoding stearoyl-CoA desatu-
rase (Scd1 [30]), in both epididymal and subcutaneous fat
depots, and acyl-CoA:diacylglycerol acyltransferase (Dgat2),
in the former depot only (Table 2).
Thirdly, seven of the 18 differentially expressed genes
were verified using qRT-PCR (Table 1). The differences in
the expression of the gene for mt-Co1 were more pro-
nounced in the epididymal than in the dorsolumbar fat
depot (Table 2).
Specific induction of mitochondrial proteins
in epididymal fat by the sHFf-F2 diet
Subunits of the mitochondrial oxidative phosphorylation
complexes were quantified in crude cell membranes pre-
pared from white adipose tissue using immunoblots (Fig. 1,
Table 3). In epididymal fat, levels of SDHA, MT-CO1,
COX6 and ATP5A1 were elevated approximately 2-fold by
the sHFf-F2 diet compared with the sHFf diet, resulting, in
the case of MT-CO1, in higher levels in epididymal than in
dorsolumbar fat in the sHFf-F2-fed animals. In the dorso-
lumbar fat, no effect of the diet on any of the analysed
antigens was observed. In contrast to the differential effect
of the sHF-F2 diet on the quantity of SDHA and ATP5A1
in two fat depots, qRT-PCR analysis (n=7–9) revealed sig-
nificant induction of transcripts for these genes by sHF-F2
diet in both epididymal fat (Sdha, 1.35±0.16 vs 2.71±0.35
AU; Atp5a1, 1.82±0.08 vs 3.97±0.75 AU) and subcutane-
ous fat (Sdha, 1.96±0.19 vs 2.75±0.26 AU; Atp5a1, 1.44±
0.23 vs 3.31±0.54 AU).
Induction of Ppargc1a, Nrf1, Cpt1a, fatty acid
oxidation and depression of fatty acid synthesis
in white adipose tissue by the sHFf-F2 diet
We hypothesised that the induction of PPARGC1A, as well
as NRF1 [18, 19], which is a downstream target for
PPARGC1A and orchestrates mitochondrial biogenesis
[19], is involved in the effect of EPA/DHA concentrate on
white adipose tissue. qRT-PCR analysis revealed approxi-
mately 3.4-fold induction of both Ppargc1a and Nrf1
transcripts in epididymal fat by the sHFf-F2 diet compared
with the sHFf diet (Figs. 2a and b). Both genes tended to be
upregulated also in dorsolumbar fat, but the effects were
much smaller and not statistically significant. Also, CPT1,
which is necessary for the translocation of fatty acid into
mitochondria, represents a downstream target for PPARG
C1A [31]. qRT-PCR analysis revealed that the liver isoform
of the gene encoding CPT1 (Cpt1a) was upregulated by the
sHFf-F2 diet in epididymal but not in dorsolumbar fat
(Fig. 2c). Positive correlations between the expressions of
genes encoding PPARGC1A and CPT1A within identical
tissues and diets were observed, while correlations between
the expression of genes encoding PPARGC1A and NRF1
were not statistically significant (Fig. 2d and legend). The
upregulation of the gene for CPT1A suggests stimulation
of fatty acid oxidation in the epididymal fat of the sHFf-F2
mice. Indeed, oxidation of oleate was 1.5- to 1.8-fold
higher in epididymal fat of the sHFf-F2 compared with the
sHFf mice, when the rate of oxidation was related either to
tissue weight, protein, or DNA (Fig. 3). In dorsolumbar fat,
similar rates were observed in both diet groups (Fig. 3).
Fatty acid synthesis was lower in epididymal fat of sHFf-
F2 than sHFf mice (83±7 vs 114±12 dpm of 3H2O in-
corporated into saponifiable fatty acids per mg of tissue
DNA; n=7).
Levels of acyl-CoAoxidase 1 (Acox1)mRNA, themarker
of peroxisomal fatty acid oxidation, were significantly
higher in mice fed the sHFf-F2 diet than in those fed the
sHFf diet, in both epididymal (0.27±0.05 vs 0.14±0.02 AU)
Fig. 1 Immunoblotting of mitochondrial proteins in epididymal fat
of the mice fed sHFf and mice fed sHFf-F2 diets. The analysis was
performed using crude cell membranes isolated from adipose tissue.
The amount of protein in each lane is indicated. Isolated mouse liver
mitochondria were used as a standard (see Table 3)
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and dorsolumbar (0.09±0.02 vs 0.04±0.01 AU) adipose
tissue. Thus, in contrast to the gene encoding CPT1A,
similar stimulation of transcription of the gene for ACOX1
was observed in both fat depots of sHFf-F2 mice (n=13).
In contrast to white adipose tissue, especially the epi-
didymal fat, no significant changes in the expression of
Ppargc1a, Nrf1 and Cpt1a were observed in liver (not
shown). Only the levels of Acox1mRNAwere significantly
higher in mice fed the sHFf-F2 than in those fed the sHFf
diet (32±1.5 vs 21±1.3 AU; n=5).
Upregulation of the markers of mitochondrial
biogenesis and β-oxidation and suppression
of lipogenic genes in adipocytes from mice
fed the composite diet cHF-F1
These experiments were designed to verify whether mito-
chondrial biogenesis and β-oxidation are stimulated when
induction of obesity by the cHF diet is reduced by re-
placement of only 15% of dietary lipids by EPA/DHA
concentrate (cHF-F1 diet). In accordance with our previous
Fig. 3 Oxidation of oleate in fat depots of mice fed sHFf (white bars) or
sHFf-F2 (black bars). Activity is expressed as pmol fatty acids·h−1·mg−1
tissue (Tissue), pmol fatty acids·h−1·mg−1 protein·10−2 (Protein), or pmol
fatty acids·h−1·μg−1 DNA (DNA). There was a different effect of diet in
fat depots (two-way ANOVA). Data are means±SEM (n=9). The tissue
DNA concentration was 0.78±0.08 and 0.76±0.11 μg DNA/mg tissue in
epididymal fat of sHFf and sHFf-F2 mice, respectively. Corresponding
values for dorsolumbar fat were 1.27±0.16 and 1.05±0.20. Significant
difference between diets
Fig. 2 Gene expression in adipose tissue. a–c Using qRT-PCR,
transcript levels were evaluated in total RNA isolated from adipose
tissue depots of mice fed the sHFf diet (white bars) or the sHFf-F2
diet (black bars). For all transcripts, the effect of diet in fat depots
was different (two-way ANOVA). Significant differences between
diets; significant differences between fat depots. Data are means±
SEM (n=9–15). d Correlation between Ppargc1a and Cpt1a mRNA
levels in epididymal fat of the mice fed sHFf (white circles) and
sHFf-F2 (black circles) and in dorsolumbar fat of the mice fed sHFf
(white squares) and sHFf-F2 (black squares). Spearman correlation
coefficients for each set of data were 0.72–0.83. Corresponding
values for the correlation between Ppargc1a and Nrf1 transcripts
were 0.38–0.62. Only the correlations between Ppargc1a and Cpt1a
transcripts (d) were statistically significant (p<0.01)
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study [8], a significant 22±7% reduction of body weight
gain was observed in the cHF-F1-fed mice compared with
the cHF-fed mice after 5 weeks of the treatment. The weight
of epididymal fat in the cHF-F1-fed mice was 24±3% lower
than in the cHF group (mean±SEM of three independent
experiments, n=10–13), while theweight of dorsolumbar fat
was not significantly different. As observed before [8], food
consumption was not affected (see Table 1 for data from a
typical experiment).
In animals fed the cHF and cHF-F1 diets (Table 1), gene
expression was studied using RNA prepared from the
adipocytes isolated from epididymal fat (Table 4). Expres-
sion of the genes for PPARGC1A, MT-CO3 and CPT1A
was enhanced by the cHF-F1 diet compared with the cHF
diet, while the gene encoding SCD1 was down-regulated.
Since PPARGC1A can induce the expression of the gene
for mitochondrial UCP1 [18, 20] and marine-derived n-3
PUFA have been shown to induce expression of this gene
in brown fat [14], the Ucp1 transcript was also measured.
However, it was barely detectable (levels were at least four
orders of magnitude lower than in interscapular brown fat)
and no induction of theUcp1 transcript by cHF-F1 diet was
observed (not shown). Levels of Ucp2 transcript were
lower in adipocytes from the cHF-F1-fed than the cHF-fed
mice, while levels of Ucp3 transcript were similar in the
two groups of mice (Table 4).
Direct effect of n-3 PUFA on adipocytes
3T3-L1 adipocytes differentiated in cell culture were
incubated for 24 h with various fatty acids: oleate alone,
oleate plus ALA, or oleate plus DHA, and Ppargc1a and
Nrf1 transcripts were quantified (Fig. 4). Compared with
oleate, both ALA and DHA significantly increased the
levels of both transcripts. The stimulation by DHA seemed
to be more pronounced than that by ALA, but the dif-
ference was not statistically significant. Similar results
were obtained in primary cultures of adipocytes (not
shown).
Discussion
The results of this study demonstrate the involvement of
white adipose tissue, in addition to the liver, brown fat and
other organs, in the mechanism whereby marine-derived
n-3 PUFA reduce adiposity and body weight. Our finding
that EPA/DHA concentrate can specifically stimulate
expression of Ppargc1a and Cpt1a, increase the content
of mitochondrial proteins and induce β-oxidation in
epididymal but not dorsolumbar fat is consistent with the
preferential reduction of adipose tissue accumulation in the
abdomen.
The idea that changes induced in white adipocytes by
EPA andDHAcould contribute to the reduction of obesity is
strongly supported by the upregulation of genes encoding
PPARGC1A and MT-CO3 and downregulation of the gene
encoding SCD1 in adipocytes prepared from epididymal fat
of the cHF-F1-fed mice. Under these conditions (mouse fed
the cHF-F1 diet), only 15% of dietary fat was replaced by
EPA/DHA concentrate, resulting in a substitution of about
10% of the fat for EPA/DHA. This led to a significant
reduction in weight gain compared with mice fed the cHF
diet.
Increased expression of Nrf1 is consistent with the
upregulation of genes for mitochondrial proteins by EPA/
DHA. Themajority of these genes (i.e.mt-Co1,mt-Co3,mt-
Nd1, mt-Nd4, mt-Atp6 and mt-Atp8) are encoded by
mitochondrial DNA. However, immunoblotting analysis
revealed that the biosynthesis of nuclear-encoded mito-
chondrial proteins (COX6, SDHA and ATP5A1) is also
upregulated. Expression of genes encoding PPARGC1A and
NRF1 is more stimulated in epididymal than in dorsolumbar
Table 4 Gene expression in adipocytes isolated from epididymal fat of mice fed cHF or cHF-F1 diet
Diet Ppargc1a mt-Co3 Cpt1a Scd1 Ucp2 Ucp3
cHF 0.14±0.03 9.25±1.02 1.40±0.32 1.57±0.18 0.87±0.11 0.82±0.02
cHF-F1 0.51±0.09a 12.81±0.64a 2.32±0.61a 0.40±0.08a 0.40±0.09a 1.01±0.03
Data are means±SEM (n=7)
aSignificant difference between diets
Fig. 4 Effect of n-3 PUFA on
gene expression in 3T3-L1 cells.
Postconfluent cells were treated
for 24 h with oleate, oleate plus
ALA, or oleate plus DHA (see
Materials and methods), and
transcripts were quantified using
qRT-PCR. Data are means±
SEM (n=12). Significant differ-
ences versus oleate
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fat, and striking fat depot-specific differences were observed
in the effect of EPA/DHA on the expression of the gene
encoding CPT1A, fatty acid oxidation activity and the
quantity of oxidative phosphorylation proteins. In contrast,
EPA/DHA induced transcripts for most of themitochondrial
proteins as well as the marker of peroxisomal fatty acid
oxidation, Acox1, to a similar extent in both fat depots.
These results suggest distinct post-transcriptional control in
different fat depots of the expression of the genes for
mitochondrial proteins and the involvement of mitochon-
dria rather than peroxisomes in the stimulatory effect of EPA
and DHA on fatty acid oxidation in epididymal fat.
Our in vitro experiments suggest that n-3 PUFA can
modulate gene expression in white adipose tissue by direct
interaction with adipocytes. PUFAof the n-3 series and their
metabolites, eicosanoids [6], are ligands [32] of various
isoforms of the peroxisome proliferator-activated receptor
(PPAR [33–35]). All PPARs (α, γ and δ) physically interact
with the gene encoding PPARGC1A [18, 34, 35], which is
upregulated by EPA/DHA in adipocytes. A recent study
indicates that treatment of ob/ob mice with rosiglitazone, a
PPARγ ligand of the thiazolidinedione family and a widely
used antidiabetic drug, increases mitochondrial mass, pal-
mitate oxidation and the expression of genes encoding
PPARGC1A, CPT1A and UCP1 in epididymal fat [36].
Except for the upregulation of the gene for UCP1, all these
effects are similar to those elicited in white adipose tissue by
EPA/DHA, suggesting that both n-3 PUFA and rosiglita-
zone induce similar metabolic changes in white adipose
tissue cells, while increasing mitochondrial oxidative ca-
pacity and stimulating glucose uptake into adipocytes.
However, in contrast to EPA/DHA, thiazolidinediones
also support an adipogenic programme [36]. Surprisingly,
rosiglitazone induces the accumulation of n-3 PUFA in
white adipose tissue of diabetic mice [37]. Whether the
mechanism of the effect of rosiglitazone depends on the
accumulation of n-3 PUFA in adipocytes remains to be
clarified.
Forced expression of the gene for PPARGC1A in both
3T3-F442A (references, see [18]) and human adipocytes [20]
induces the conversion of adipocytes to energy-dissipating
cells, including the recruitment of the gene for UCP1. Low
levels of transgenic UCP1 in white adipose tissue may
protect mice against obesity [17] while stimulating oxida-
tion of fatty acids [28] and mitochondrial biogenesis [23],
and depressing lipogenesis [22] in adipocytes. Also, leptin
[38, 39], β3-adrenergic agonists [40] and bezafibrate [41]
have similar effects in rodents [38, 41], including induction
of the genes for CPT1A [39, 41] and PPARGC1A [38] in
white adipose tissue. Apparently, various stimuli can
convert adipocytes into fat-burning cells and depress the
accumulation of body fat, even without induction of UCPs
in these cells, as documented by the effect of EPA/DHA.
Lack of recruitment of UCP1 in the EPA/DHA-treated
mice may be explained by the absence of other cofactors or
hormones required in addition to PPARGC1A [18, 20]. The
absence of UCP1 also suggests that the increase in fatty
acid oxidation occurs in white rather than brown fat cells.
This idea is supported by the induction of the gene for
CPT1A, which is preferentially expressed in white adipose
tissue in mice [42]. Because of the low activity of CPT1A,
the rate of β-oxidation in white adipose tissue is normally
low and fatty acids are directed to esterification [42, 43].
Thus, the enhancement of fatty acid oxidation in white
adipose tissue by EPA/DHA concentrate could depend on
the increase in the expression of the gene encoding CPT1A.
Decreased production of malonyl CoA due to suppression
of lipogenesis may result in further augmentation of fatty
acid oxidation in mitochondria via the CPT1A-mediated
mechanism [44].
It was found recently that expression of the gene encod-
ing PPARGC1A is reduced in the adipose tissue of morbid-
ly obese subjects [45] and inversely correlated with adipose
cell mass [46], and that Ppargc1a polymorphisms segregate
with obesity [47] and type 2 diabetes [48]. Onset of obesity
in ob/ob mice is associated with downregulation of genes
coding for mitochondrial proteins [36], and heat production
by white adipose tissue cells from obese humans is lower
than in lean individuals [49]. All these findings are com-
patible with the hypothesis that changes in fuel partitioning
and reduced oxidation of lipids in white adipocytes con-
tribute to the development of obesity and type 2 diabetes.
In conclusion, we show for the first time that dietary EPA
and DHA preferentially upregulate genes for mitochondrial
proteins, including their regulatory genes Ppargc1a and
Nrf1, and increaseβ-oxidationwhile depressing lipogenesis
in abdominal fat. This metabolic switch is induced indepen-
dently of ALA intake and could reduce the development of
obesity. Relatively minor changes in the composition of lipids
in an obesity-promoting diet exert surprisingly pronounced
effects. Our findings have important implications for the
design of novel dietary and pharmacological strategies for
the prevention and treatment of obesity and the metabolic
syndrome.
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